Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
- PMID: 27225869
- PMCID: PMC4880966
- DOI: 10.1038/srep26800
Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
Abstract
Cirrhosis is associated with brain dysfunction known as hepatic encephalopathy (HE). The mechanisms behind HE are unclear although hyperammonemia and systemic inflammation through gut dysbiosis have been proposed. We aimed to define the individual contribution of specific gut bacterial taxa towards astrocytic and neuronal changes in brain function using multi-modal MRI in patients with cirrhosis. 187 subjects (40 controls, 147 cirrhotic; 87 with HE) underwent systemic inflammatory assessment, cognitive testing, stool microbiota analysis and brain MRI analysis. MR spectroscopy (MRS) changes of increased Glutamate/glutamine, reduced myo-inositol and choline are hyperammonemia-associated astrocytic changes, while diffusion tensor imaging (DTI) demonstrates changes in neuronal integrity and edema. Linkages between cognition, MRI parameters and gut microbiota were compared between groups. We found that HE patients had a significantly worse cognitive performance, systemic inflammation, dysbiosis and hyperammonemia compared to controls and cirrhotics without HE. Specific microbial families (autochthonous taxa negatively and Enterobacteriaceae positively) correlated with MR spectroscopy and hyperammonemia-associated astrocytic changes. On the other hand Porphyromonadaceae, were only correlated with neuronal changes on DTI without linkages with ammonia. We conclude that specific gut microbial taxa are related to neuronal and astrocytic consequences of cirrhosis-associated brain dysfunction.
Figures
Similar articles
-
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.Hepatology. 2015 Oct;62(4):1260-71. doi: 10.1002/hep.27819. Epub 2015 May 6. Hepatology. 2015. PMID: 25820757 Free PMC article.
-
Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis.Metab Brain Dis. 2014 Dec;29(4):1017-25. doi: 10.1007/s11011-014-9507-6. Epub 2014 Mar 4. Metab Brain Dis. 2014. PMID: 24590688 Free PMC article. Clinical Trial.
-
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice.Hepatology. 2016 Oct;64(4):1232-48. doi: 10.1002/hep.28696. Epub 2016 Jul 29. Hepatology. 2016. PMID: 27339732 Free PMC article.
-
The role of microbiota in hepatic encephalopathy.Gut Microbes. 2014 May-Jun;5(3):397-403. doi: 10.4161/gmic.28684. Epub 2014 Apr 1. Gut Microbes. 2014. PMID: 24690956 Free PMC article. Review.
-
The Link between Gut Microbiota and Hepatic Encephalopathy.Int J Mol Sci. 2022 Aug 12;23(16):8999. doi: 10.3390/ijms23168999. Int J Mol Sci. 2022. PMID: 36012266 Free PMC article. Review.
Cited by
-
The RIVET RCT: Rifamycin SV MMX improves muscle mass, physical function, and ammonia in cirrhosis and minimal encephalopathy.Hepatol Commun. 2024 Feb 3;8(2):e0384. doi: 10.1097/HC9.0000000000000384. eCollection 2024 Feb 1. Hepatol Commun. 2024. PMID: 38315140 Free PMC article. Clinical Trial.
-
Liver cirrhosis and complications from the perspective of dysbiosis.Front Med (Lausanne). 2024 Jan 16;10:1320015. doi: 10.3389/fmed.2023.1320015. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38293307 Free PMC article. Review.
-
What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?Life (Basel). 2023 Dec 25;14(1):37. doi: 10.3390/life14010037. Life (Basel). 2023. PMID: 38255652 Free PMC article. Review.
-
The contributions of bacteria metabolites to the development of hepatic encephalopathy.Liver Res. 2023 Dec;7(4):296-303. doi: 10.1016/j.livres.2022.11.005. Epub 2022 Nov 15. Liver Res. 2023. PMID: 38221945 Free PMC article.
-
Disease- and stage-specific alterations of the oral and fecal microbiota in Alzheimer's disease.PNAS Nexus. 2023 Dec 11;3(1):pgad427. doi: 10.1093/pnasnexus/pgad427. eCollection 2024 Jan. PNAS Nexus. 2023. PMID: 38205031 Free PMC article.
References
-
- Shawcross D. L., Davies N. A., Williams R. & Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. Journal of hepatology 40, 247–254 (2004). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
